These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 32862716

  • 1. Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial.
    Willemsen LM, Janssen PWA, Peper J, Soliman-Hamad MA, van Straten AHM, Klein P, Hackeng CM, Sonker U, Bekker MWA, von Birgelen C, Brouwer MA, van der Harst P, Vlot EA, Deneer VHM, Chan Pin Yin DRPP, Gimbel ME, Beukema KF, Daeter EJ, Kelder JC, Tijssen JGP, Rensing BJWM, van Es HW, Swaans MJ, Ten Berg JM.
    Circulation; 2020 Nov 10; 142(19):1799-1807. PubMed ID: 32862716
    [Abstract] [Full Text] [Related]

  • 2. A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial.
    Willemsen LM, Janssen PWA, Hackeng CM, Kelder JC, Tijssen JGP, van Straten AHM, Soliman-Hamad MA, Deneer VHM, Daeter EJ, Sonker U, Klein P, Ten Berg JM.
    Am Heart J; 2020 Feb 10; 220():237-245. PubMed ID: 31884246
    [Abstract] [Full Text] [Related]

  • 3. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).
    Kulik A, Abreu AM, Boronat V, Kouchoukos NT, Ruel M.
    Contemp Clin Trials; 2018 May 10; 68():45-51. PubMed ID: 29551675
    [Abstract] [Full Text] [Related]

  • 4. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.
    Zhao Q, Zhu Y, Xu Z, Cheng Z, Mei J, Chen X, Wang X.
    JAMA; 2018 Apr 24; 319(16):1677-1686. PubMed ID: 29710164
    [Abstract] [Full Text] [Related]

  • 5. Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery.
    Saw J, Wong GC, Mayo J, Bernstein V, Mancini GB, Ye J, Skarsgard P, Starovoytov A, Cairns J.
    Heart; 2016 May 15; 102(10):763-9. PubMed ID: 26891756
    [Abstract] [Full Text] [Related]

  • 6. Ticagrelor versus aspirin and vein graft patency after coronary bypass: A randomized trial.
    Kulik A, Abreu AM, Boronat V, Kouchoukos NT, Ruel M.
    J Card Surg; 2022 Mar 15; 37(3):563-570. PubMed ID: 34961950
    [Abstract] [Full Text] [Related]

  • 7. Influence of lipoproteins and antiplatelet agents on vein graft patency 1 year after coronary artery bypass grafting.
    Zhu J, Zhu Y, Zhang M, Xue Q, Hu J, Liu H, Wang R, Wang X, Zhao Q.
    J Thorac Cardiovasc Surg; 2022 Mar 15; 163(3):1030-1039.e4. PubMed ID: 32359899
    [Abstract] [Full Text] [Related]

  • 8. Ticagrelor for patients undergoing coronary artery bypass grafting: A meta-analysis of randomized controlled trials.
    Xiang F, Lin Y, Chen B.
    Perfusion; 2023 May 15; 38(4):698-705. PubMed ID: 35403510
    [Abstract] [Full Text] [Related]

  • 9. Correlates of saphenous vein graft hyperplasia and occlusion 1 year after coronary artery bypass grafting: analysis from the CASCADE randomized trial.
    Une D, Kulik A, Voisine P, Le May M, Ruel M.
    Circulation; 2013 Sep 10; 128(11 Suppl 1):S213-8. PubMed ID: 24030409
    [Abstract] [Full Text] [Related]

  • 10. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
    Gao G, Zheng Z, Pi Y, Lu B, Lu J, Hu S.
    J Am Coll Cardiol; 2010 Nov 09; 56(20):1639-43. PubMed ID: 21050973
    [Abstract] [Full Text] [Related]

  • 11. SUPERIOR SVG: no touch saphenous harvesting to improve patency following coronary bypass grafting (a multi-Centre randomized control trial, NCT01047449).
    Deb S, Singh SK, de Souza D, Chu MWA, Whitlock R, Meyer SR, Verma S, Jeppsson A, Al-Saleh A, Brady K, Rao-Melacini P, Belley-Cote EP, Tam DY, Devereaux PJ, Novick RJ, Fremes SE, SUPERIOR SVG Study Investigators.
    J Cardiothorac Surg; 2019 May 02; 14(1):85. PubMed ID: 31046806
    [Abstract] [Full Text] [Related]

  • 12. Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial.
    Mehta RH, Ferguson TB, Lopes RD, Hafley GE, Mack MJ, Kouchoukos NT, Gibson CM, Harrington RA, Califf RM, Peterson ED, Alexander JH, Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Investigators.
    Circulation; 2011 Jul 19; 124(3):280-8. PubMed ID: 21709060
    [Abstract] [Full Text] [Related]

  • 13. Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative study.
    Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Kern KB, Sethi G, Sharma GV, Khuri S.
    Circulation; 1994 Mar 19; 89(3):1138-43. PubMed ID: 8124800
    [Abstract] [Full Text] [Related]

  • 14. Composite versus conventional coronary artery bypass grafting strategy for the anterolateral territory: study protocol for a randomized controlled trial.
    Drouin A, Noiseux N, Chartrand-Lefebvre C, Soulez G, Mansour S, Tremblay JA, Basile F, Prieto I, Stevens LM.
    Trials; 2013 Aug 26; 14():270. PubMed ID: 23971858
    [Abstract] [Full Text] [Related]

  • 15. Relative importance of patient, procedural and anatomic risk factors for early vein graft thrombosis after coronary artery bypass graft surgery.
    McLean RC, Nazarian SM, Gluckman TJ, Schulman SP, Thiemann DR, Shapiro EP, Conte JV, Thompson JB, Shafique I, McNicholas KW, Villines TC, Laws KM, Rade JJ.
    J Cardiovasc Surg (Torino); 2011 Dec 26; 52(6):877-85. PubMed ID: 22051997
    [Abstract] [Full Text] [Related]

  • 16. Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study).
    Deb S, Cohen EA, Singh SK, Une D, Laupacis A, Fremes SE, RAPS Investigators.
    J Am Coll Cardiol; 2012 Jul 03; 60(1):28-35. PubMed ID: 22742399
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.
    Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB, Lorenz TJ, Goyal A, Gibson M, Mack MJ, Gennevois D, Califf RM, Kouchoukos NT, PREVENT IV Investigators.
    JAMA; 2005 Nov 16; 294(19):2446-54. PubMed ID: 16287955
    [Abstract] [Full Text] [Related]

  • 18. Sequential Versus Individual Saphenous Vein Grafting During Coronary Arterial Bypass Surgery.
    Park SJ, Kim HJ, Kim JB, Jung SH, Choo SJ, Lee JW, Chung CH.
    Ann Thorac Surg; 2020 Apr 16; 109(4):1165-1173. PubMed ID: 31539513
    [Abstract] [Full Text] [Related]

  • 19. Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events: A Randomized Controlled Trial.
    Rodés-Cabau J, Jolly SS, Cairns J, Mansour S, L'Allier PL, Teefy PJ, Graham JJ, Le May MR, Cantor WJ, Wood D, Balasubramanian K, DeLarochellière R, Dzavik V, VELETI II Investigators (Sealing Moderate Coronary Saphenous Vein Graft Lesions With Paclitaxel-Eluting Stents).
    Circ Cardiovasc Interv; 2016 Nov 16; 9(11):. PubMed ID: 27815344
    [Abstract] [Full Text] [Related]

  • 20. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study.
    Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG, Thottapurathu L, Krasnicka B, Ellis N, Anderson RJ, Henderson W, VA Cooperative Study Group #207/297/364.
    J Am Coll Cardiol; 2004 Dec 07; 44(11):2149-56. PubMed ID: 15582312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.